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Abstract
Unbiased genomic screening analyses have highlighted novel immunomodulatory 
properties of the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D). 
However, clearer interpretation of the resulting gene expression data is limited by cell 
model specificity. The aim of the current study was to provide a broader perspective 
on common gene regulatory pathways associated with innate immune responses to 
1,25(OH)2D, through systematic re-interrogation of existing gene expression databases 
from multiple related monocyte models (the THP-1 monocytic cell line (THP-1), monocyte-
derived dendritic cells (DCs) and monocytes). Vitamin D receptor (VDR) expression is 
common to multiple immune cell types, and thus, pathway analysis of gene expression 
using data from multiple related models provides an inclusive perspective on the 
immunomodulatory impact of vitamin D. A bioinformatic workflow incorporating 
pathway analysis using PathVisio and WikiPathways was utilized to compare each set 
of gene expression data based on pathway-level context. Using this strategy, pathways 
related to the TCA cycle, oxidative phosphorylation and ATP synthesis and metabolism 
were shown to be significantly regulated by 1,25(OH)2D in each of the repository models 
(Z-scores 3.52–8.22). Common regulation by 1,25(OH)2D was also observed for pathways 
associated with apoptosis and the regulation of apoptosis (Z-scores 2.49–3.81). In 
contrast to the primary culture DC and monocyte models, the THP-1 myelomonocytic cell 
line showed strong regulation of pathways associated with cell proliferation and DNA 
replication (Z-scores 6.1–12.6). In short, data presented here support a fundamental role 
for active 1,25(OH)2D as a pivotal regulator of immunometabolism.
Introduction
In recent years, studies in vivo and in vitro have shown 
that vitamin D is able to influence biological responses 
that extend far beyond its classical effects on skeletal 
homeostasis. Prominent among these extra-skeletal 
effects is the interaction between vitamin D and the 
immune system, including regulation of both innate and 
adaptive immune responses (Adams & Hewison 2008, 
Hewison 2011, Wei & Christakos 2015). As a consequence 
of these observations, vitamin D deficiency has been 
linked to increased risk of bacterial and viral infection 
(Nnoaham & Clarke 2008, Lake & Adams 2011), as well as 
inflammatory and autoimmune disease (Cantorna 2012, 
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Jeffery et  al. 2016). The ability of supplementary or 
therapeutic vitamin D to prevent or improve these 
immune disorders is much less clear and is the subject of 
randomized placebo control trials currently underway. 
Crucially, improved understanding of the mechanisms 
that underpin the immunomodulatory actions of 
vitamin D has greatly helped to improve the design 
and outcome of clinical trials. In particular, unbiased 
analysis of gene responses to vitamin D supplementation 
has uncovered previously unrecognized immune targets 
for vitamin D (Liu et al. 2006, Chun et al. 2014) that are 
now key markers of vitamin D function in 
supplementation trials.
The initial observation linking vitamin D and immune 
function was detection of the nuclear vitamin D receptor 
(VDR) in lymphocytic and myeloid cells (Bhalla et al. 1983, 
Mangelsdorf et al. 1984), indicating that these cells are able 
to respond to the active form of vitamin D, 1,25(OH)2D, 
which binds with VDR. Further studies showed that 
cells from innate immune system such as monocytes/
macrophages (Kreutz et al. 1993) and dendritic cells (DC) 
(Hewison et al. 2003) are also able to synthesize 1,25(OH)2D 
from the inactive precursor 25-hydroxyvitamin D (25D), 
the main circulating form of vitamin D. As the principal 
effect of dietary vitamin D supplementation is to raise 
serum levels of 25D, the ability of monocytes and DCs to 
convert 25D to 1,25(OH)2D provides a localized, autocrine, 
pathway by which enhanced 25D can influence both 
innate and adaptive immunity (Liu et al. 2006, Jeffery et al. 
2012). These observations placed monocytes and DCs at 
the center of the immunomodulatory activity of vitamin 
D. Synthesis of 1,25(OH)2D by these cells has the potential 
to influence endogenous innate immune cell function in 
the form of enhanced antibacterial activity (Liu et al. 2006, 
Hewison 2011) and/or modulated antigen presentation 
(Hewison et  al. 2003, Jeffery et  al. 2012). Furthermore, 
1,25(OH)2D generated by monocytes and/or DCs may also 
impact adaptive immune function by exerting exogenous 
effects on T cells or B cells expressing VDR (Jeffery et al. 
2012). Despite this, our understanding of the broader 
impact of vitamin D on cells from the innate immune 
system such as monocytes, macrophages and DCs remains 
far from clear.
Recent genome-wide expression studies using a 
monocyte-derived DC model highlighted the potential 
role of pathways associated with glucose metabolism, the 
TCA cycle and oxidative phosphorylation in mediating 
the effects of 1,25(OH)2D in promoting a tolerogenic DC 
phenotype (Ferreira et al. 2015). The aim of the current 
study was to provide a broader analysis of monocyte/DC 
responses to 1,25(OH)2D using existing gene expression 
repositories for multiple models of innate immune 
function. A meta-analysis of various datasets has been 
performed using an integrative workflow of open-
source bioinformatics tools in order to give a biological 
context to the genes that are significantly modulated 
by 1,25(OH)2D. Finally, a comparison between the 
immune cell types selected has been applied to highlight 
the common biological processes that are altered by 
vitamin D.
Materials and methods
Workflow overview
A workflow was developed that utilizes and integrates 
gene expression data from public repositories and places 
them in a biological context. Supplementary Figure  1 
(see section on supplementary data given at the end of 
this article) illustrates step by step the different tools and 
methods used in the analysis workflow. The first procedure 
consisted of open and free modules in ArrayAnalysis to 
(i) perform a data quality check, (ii) normalize the raw 
transcriptomic data and (iii) perform a statistical analysis 
to obtain the parameters that show gene expression 
changes. The processed datasets were then applied to 
PathVisio, v. 3.2.4 software (van Iersel et al. 2008, Kutmon 
et al. 2015b) in order to perform statistical analyses that 
highlight the biological processes significantly altered as a 
consequence of gene expression changes and to visualize 
them in pathway diagrams from the WikiPathways 
pathway repository downloaded January 2017 (Kutmon 
et  al. 2016). Comparison of the pathways shown to be 
significantly altered between the different cell types using 
PathVisio and WikiPathways was also represented by heat 
maps diagrams. In another approach, genes shown to be 
regulated by 1,25(OH)2D in all three cell models were used 
to identify enriched biological processes by gene ontology 
(GO) analysis and the results were visualized in biological 
networks using ClueGO, v 2.3.3 (Bindea et al. 2009), an 
app of Cytoscape 3.4.0 (Smoot et al. 2011) (Supplementary 
Fig.  1). This workflow is designed in a user-friendly 
fashion that does not require programming skills. In order 
to reproduce this workflow, it is recommended to use 
the latest versions of designated software. Furthermore, 
it is also important that gene annotation database and 
pathways repositories used in the analysis are regularly 
updated.
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Transcriptomic datasets
Publically available transcriptomic data sets for 
1,25(OH)2D-treated monocytes and dendritic cells (DC) 
were selected from ArrayExpress (https://www.ebi.
ac.uk/arrayexpress/, (Kolesnikov et  al. 2015)) and Gene 
Expression Omnibus (GEO, http://ncbi.nlm.nih.gov/
geo/, (Barrett & Edgar 2006)). Selection criteria were 
based on gene expression studies performed in human 
cells including monocytic cell lines, monocytes and 
monocyte-derived DCs treated with 1,25(OH)2D: THP-1 
cells (GSE52819 (Verway et  al. 2013)), dendritic cells 
(GSE13762 (Széles et  al. 2009)) and human monocytes 
(GSE56490 (Ferreira et  al. 2015)). The selection of the 
three studies was based on experimental design and 
quality control analysis of the raw data. In all studies, 
data were derived from human immune cells treated 
with 1,25(OH)2D or from control (vehicle-treated) cells 
(Supplementary Table  1). In addition to the three cell 
models outlined previously, preliminary analyses were 
also carried out using other 1,25(OH)2D-treated cell data 
repositories: THP-1 cells (GSE60102 (Nurminen et  al. 
2015)) and human monocytes (GSE46268 (Wheelwright 
et al. 2014)). In addition, the data for GSE13762 (Széles 
et  al. 2009) included both immature and mature DC, 
and both these models were included in the preliminary 
analysis. Finally, as a negative control, the preliminary 
pathway analysis included a 1,25(OH)2D-treated B cell 
dataset (GSE22523 (Lisse et al. 2011)). Because of missing 
raw data, incomplete gene annotation, incompatibility 
with ArrayAnalysis and non-monocyte origin, some data 
from the preliminary analysis were not included in the 
main analysis of this study, but relevant findings related 
to the data were addressed in the ‘Results’ section.
Pre-processing raw data and statistical data analysis 
in ArrayAnalysis
Unprocessed transcriptomics data were collected from 
the repositories and processed using the online 
workflow of ArrayAnalysis performed in January 2017 
(https://www.arrayanalysis.org (Eijssen et  al. 2013)) to 
obtain quality control reports, normalized data and 
perform statistical analysis. The workflow uses an R 
script as a core module with functions from several 
Bioconductor libraries. Quality control showed that there 
was no need to exclude any samples in the three selected 
transcriptomic datasets (data not shown). Depending 
on the microarray technology used, the normalization 
algorithm was selected. RMA method was used to 
normalize GSE52819 (Verway et al. 2013) and GSE56490 
(Ferreira et  al. 2015). GC-RMA method was applied to 
GSE13762 (Szeles et  al. 2009). Statistical analysis of the 
normalized data to determine genes that are significantly 
altered (up/downregulated) was carried out with a second 
module from ArrayAnalysis including the moderated 
t-test from the R/Bioconductor package limma (Ritchie 
et  al. 2009). The output is a table with the expression 
parameters for each gene showing fold-change (FC), in a 
log scale after 1,25(OH)2D treatment, and the significance 
of changes by the Benjamini–Hochberg adjusted P value. 
Based on statistical gene expression parameters, the 
significantly up/downregulated genes were identified 
using the criteria: absolute log2FC ≥0.26 and adjusted 
P value <0.05. The average expression (AE) was used 
to filter out lowly expressed genes, and the cut-off was 
specific for each dataset based on the density plot of 
the intensities after normalization: THP-1 AE >4.25; 
immature DC AE >3.86 and monocytes AE >9.5 (Table 1).
Pathway statistics and analysis in PathVisio
PathVisio v. 3.2.4 (van Iersel et al. 2008, Kutmon et al. 
2015b), an open-source pathway creation and analysis 
tool, was used to contextualize significantly altered 
genes, and altered biological processes were visualized 
using the biological pathway repository WikiPathways 
(Kutmon et  al. 2016). Utilizing the BridgeDb identifier 
mapping feature released on 18 October 2016 (http://
www.bridgedb.org/) (van Iersel et  al. 2010), PathVisio 
recognizes genes (probe) identifiers from the most used 
databases and microarray platforms such as NCBI and 
Table 1 Regulation of gene expression by 1,25(OH)2D in THP-1, dendritic cells and monocyte models.
Dataset Type of cell Genes measured Genes significantly altered Genes upregulated Genes downregulated
Verway et al. (2013) THP-1 21,664 2652 1194 1458
Széles et al. (2009) Immature DC 20,111 2093 1130 963
Ferreira et al. (2015) Monocytes 21,664 1248 525 723
Total number of genes measured for each gene expression repository and the number of genes with significantly altered expression. Genes with an 
absolute log fold-change >0.26 and adjusted P value <0.05 were considered as regulated. Based on the expression parameter log fold-change genes are 
classified by upregulated (log fold-change >0.26) and downregulated (log fold-change <−0.26).
Downloaded from Bioscientifica.com at 10/21/2020 09:43:20AM
via Maastricht University
https://doi.org/10.1530/JME-17-0186
http://jme.endocrinology-journals.org © 2018 Society for Endocrinology
Printed in Great Britain
Published by Bioscientifica Ltd.
98A Muñoz Garcia et al. Pathway analysis of innate 
immune vitamin D
60 2:Journal of Molecular 
Endocrinology
Affymetrix. This identifier mapping database (Homo 
sapiens Derby Ensembl 85 gene database) enables 
linking of statistical values from analyzed data to the 
corresponding gene boxes in the pathway diagrams 
of WikiPathways. In the analysis, the curated human 
pathways collection (released April 2017, http://data.
wikipathways.org/20170410/gpml/) of WikiPathways 
was used. For pathway analysis, a criterion is chosen to 
select genes that are significantly altered within each 
dataset based on the expression difference parameter of 
FC (on log2 scale) and the significance of that change 
is represented as the adjusted P value (<0.05). PathVisio 
performs an overrepresentation analysis taking into 
account all genes measured (N), genes that satisfy the 
criterion (R), genes measured in the experiment that are 
present in the pathway (n) and genes in the pathway 
measured in the experiment that satisfy the criteria (r):
Z =
r - n
R
N
n
R
N
1-
R
N
1-
n - 1
N - 1
score
















The Z-score is used to measure how significantly a 
subset of genes is altered in a certain pathway compared to 
the complete dataset. In our analysis, biological pathways 
that have a Z-score equal to or above 1.96 are considered 
significantly altered. The function heatmap.2 from the R 
library gplots (v.3.0.1) was used to create a heatmap that 
compared and hierarchically clustered pathways for each 
of the datasets based on Z-scores.
GO analysis with ClueGO in Cytoscape
GO analysis of the common significantly altered genes 
(absolute log2FC ≥0.26 and adjusted P value <0.05) 
in the three types of immune cells was performed to 
identify and visualize which GO biological process 
terms were significantly overrepresented. Within the 
commonly used open-source network analysis tool 
Cytoscape, v. 3.4 (Smoot et al. 2011), the ClueGO app, 
v 2.3.3 performs GO analysis to group a set of genes in 
GO terms minimizing redundancy and display their 
relationship in a network. Connections between the 
GO nodes containing a common subset of genes were 
calculated with kappa statistics based on the correlated 
genes that are grouped.
Results
Differentially expressed genes in 1,25(OH)2D-treated 
THP1 cells, dendritic cells and monocytes
A preliminary pathway analysis of multiple THP-
1, monocyte and DC datasets revealed common 
regulation of several key cell pathways by 1,25(OH)2D 
in cells from the myeloid lineage: electron transport, 
oxidative phosphorylation, the TCA cycle, glycolysis 
and gluconeogenesis and apoptosis. By contrast, the 
non-myeloid B cell gene expression dataset showed 
no similarity with the myeloid effects of 1,25(OH)2D, 
underlining the lineage-specific effects of 1,25(OH)2D 
(Supplementary Fig. 2). From this initial pathway analysis, 
it was also interesting to note that 1,25(OH)2D regulation 
of pathways associated with the cell cycle and cell 
proliferation were only observed in the myeloid leukemic 
cell line THP-1 and not the other non-neoplastic primary 
cell models used in the study (Supplementary Fig.  2). 
Because of incomplete raw data or gene annotation, 
or incompatibility with ArrayAnalysis, further, more 
detailed, pathway analysis was restricted to raw datasets 
for GSE52819, GSE13762 and GSE56490.
Pathway analysis reveals altered biological 
processes based on molecular changes in 
1,25(OH)2D-treated immune cells
Pathway overrepresentation analysis performed on 
immune cell datasets GSE52819, GSE13762 and GSE56490 
generated a list of biological processes regulated by 
1,25(OH)2D in each of the three different innate immune 
cell models. For each cell type, the significantly altered 
pathways were selected, and their Z-scores plotted 
and clustered in a heatmap (Fig.  1) showing Z-score 
comparisons for major affected pathways between the 
three cell models. Data indicate that 1,25(OH)2D-regulated 
pathways were either cell specific or common to all three 
models. Pathways related to DNA replication, the cell 
cycle and cancer (retinoblastoma) showed high Z-scores 
and were more strongly regulated by 1,25(OH)2D in 
THP-1 cells, consistent with the proliferative leukemic 
nature of this cell line. By contrast, primary cells (DCs 
and monocytes) showed stronger 1,25(OH)2D regulation 
of pathways associated with glycolysis/gluconeogenesis 
and the apoptosis-related network due to altered Notch3 
in ovarian cancer pathway relative to THP-1 cells, albeit at 
lower Z-scores than observed for THP-1-specific pathways. 
Pathways associated with apoptosis and apoptosis 
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modulation and signaling also showed lower Z-scores, 
but were equally induced by 1,25(OH)2D in THP-1 cells, 
DCs and monocytes. The highest Z-score for 1,25(OH)2D-
regulated pathways common to all three cell models 
was for pathways related to the TCA cycle, oxidative 
phosphorylation and the electron transport chain.
GO analysis shows metabolic, immunological and 
apoptotic processes altered by 1,25D in THP-1 cells, 
dendritic cells and monocytes
ArrayAnalysis processing of GSE52819, GSE13762 and 
GSE56490 datasets was carried out to define the number 
of genes measured and number of genes significantly 
regulated by 1,25(OH)2D in each of the three cell models 
(Table 1). Further analysis of these data showed that a total 
of 230 genes were significantly regulated by 1,25(OH)2D in 
all three cell models (Fig. 2), and these genes were selected 
for subsequent GO analysis.
GO analysis using the list of 230 commonly altered 
genes was carried out using ClueGO in Cytoscape to 
display networks of overrepresented biological processes 
associated with this list. A total of 39 groups of GO 
terms resulted in the identification of three broad sub-
networks common to each of the cell models (Fig. 3 and 
Supplementary Fig. 3A and B).
The first of these networks was associated with 
bioenergetic GO terms including the electron transport 
chain (GO:22904), oxidation-regulation process 
(GO:55114), oxidative phosphorylation (GO:6119), 
tricarboxylic acid cycle (GO:6099) and canonical glycolysis 
(GO:61621) (Fig. 3). A second sub-network was based on 
immunological GO terms such as responses to molecules 
of bacterial origin (GO:2237), cytokine production 
(GO:1816), inflammatory response (GO:6954) and myeloid 
cell differentiation (GO:30099) (Supplementary Fig.  3A). 
Figure 1
Common altered pathways in 1,25(OH)2D-treated 
THP-1, DCs and monocytes. Heat map 
representing Z-scores for pathways significantly 
altered by 1,25(OH)2D after performing a 
pathway analysis on datasets for THP-1, DCs and 
monocytes treated with 1,25(OH)2D. Z-Scores 
>1.96 indicate that more genes are significantly 
altered in this pathway compared to the 
complete dataset.
Figure 2
1,25(OH)2D-regulated genes in THP-1 cells, DCs and monocytes. Venn 
diagrams showing numbers of common and cell-specific genes regulated 
by 1,25(OH)2D in THP-1 cells, DCs and monocytes. Genes with an absolute 
log2 fold-change >0.26 and adjusted P value <0.05 were considered as 
regulated.
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The final network identified that groups of apoptotic 
processes such as intrinsic apoptotic signaling (GO:97193) 
and negative regulation of apoptotic signaling 
(GO:2001234) (Supplementary Fig. 3B).
Visualization of 1,25(OH)2D-induced changes in gene 
expression in THP-1 cells, DCs and monocytes on 
altered metabolic pathways
Pathways related to ATP metabolism showed high Z-scores 
(>1.96), indicating strong regulation by 1,25(OH)2D 
(Fig.  2). To investigate the significant changes in gene 
expression in more depth, the effect of 1,25(OH)2D on 
gene expression was visualized on the altered metabolic 
pathways discovered with pathway analysis, i.e., electron 
transport chain, oxidative phoshorylation and TCA cycle 
and glycolysis.
1,25(OH)2D and the electron transport chain
In the human electron transport chain pathway 
(Dahlquist et  al. 2016a; http://wikipathways.org/index.
php/Pathway:WP111), significantly upregulated or 
downregulated genes (adj. P value <0.05) in the three 
immune cells treated with 1,25(OH)2D compared to 
untreated cells were collectively visualized. Overall, the 
electron transport chain was activated by 1,25(OH)2D in 
the three immune cells. Biological data in Fig.  4 shows 
in all three cell types a significant increase in expression 
by 1,25(OH)2D of genes associated with electron transport 
chain complexes I (NDUFA2, NDUFA3, NDUFA8, NDUFB9, 
NDUFA10, NDUFB5, NDUFAB1, NDUFS3, NDUFV1, 
NDUFS1), complex II (SDHB), complex III (UQRC1–2), 
complex IV (COX4l1, COX5A) and complex V (ATP5A1, 
ATP5B, ATP5C1, ATP5G1, ATP5L). Interestingly, the 
gene expression of the uncoupling protein 2 (UCP2) is 
Figure 3
ClueGO gene ontology analysis of common 1,25(OH)2D-regulated bioenergetics genes in THP-1 cells, DCs and monocytes. Cytoscape analysis showing 
overrepresented bioenergetic pathways for 1,25(OH)2D-treated THP-1 cells, DCs and monocytes. Colors represent the GO group, each node is a GO 
biological process and the edges shows the connectivity between each node based on the connection of the genes that contain. The size of the nodes 
depends on the amount of genes that are grouped. Nodes with no connections are colored in gray.
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significantly (adj. P value <0.05) downregulated in THP-1 
cells and monocytes by 1,25(OH)2D, but unchanged in 
dendritic cells.
1,25(OH)2D and oxidative phosphorylation
In the oxidative phosphorylation pathway (Waagmeester 
et  al. 2017; http://wikipathways.org/index.php/
Pathway:WP623) all significantly changed genes were 
upregulated, demonstrating that this process is activated 
by 1,25(OH)2D in THP-1 cells, DCs and monocytes. 
Biological data in Fig.  5 show that specifically genes 
related to ATP synthase (ATPG3, ATP5G1, ATP5B, 
ATP5G1, ATP5A1, ATP5L) and nicotinamide nucleotide 
transhydrogenase (NDUFA3, NDUFS3, NDUFV1, NDUFA10, 
NDUFA8, NUDFB9 NDUFS1, NDUFB5, NDUFAB1, NDUFA2) 
are significantly (adj. P value <0.05) upregulated by 
1,25(OH)2D in each of the cell models.
Figure 4
Effect of 1,25(OH)2D on genes associated with the electron transport chain. Visualization of changes in gene expression after 1,25(OH)2D treatment in 
THP-1 cells, DCs and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to red (upregulated) over white (unchanged). 
Adjusted P-values <0.05 are shown in green.
Figure 5
Effect of 1,25(OH)2D on genes associated with oxidative phosphorylation. Visualization of changes in gene expression after 1,25(OH)2D treatment in 
THP-1 cells, DCs and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to red (upregulated) over white (unchanged). 
Adjusted P-values <0.05 are shown in green.
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1,25(OH)2D and the TCA cycle and glycolysis
In the TCA cycle (Dahlquist et  al. 2016b http://
wikipathways.org/index.php/Pathway:WP78), the 
process that produces energy by oxidation of acetyl-
CoA, 1,25(OH)2D upregulates genes involved in the 
conversion of acetyl-CoA in carbohydrate and chemical 
energy. 1,25(OH)2D increased the expression of ACO2, 
IDH3, IDH4B, DLD, SUCLG1, SDHB and MDH2 and only 
the expression of IDH2, which functions in the opposite 
direction of the cycle, was significantly (adj. P value 
<0.05) downregulated (Fig.  6). Glucose metabolism was 
also affected by 1,25(OH)2D, with enzymes such as HK2, 
PFKM and FBP1 being significantly (adj. P value <0.05) 
upregulated after treatment (Supplementary Fig. 4).
1,25(OH)2D and cell proliferation
Analysis of both THP-1 cell datasets (18, 19) revealed that 
1,25(OH)2D had a significant effect on genes associated 
with the cell cycle (Conklin et  al. 2017 https://www.
wikipathways.org/instance/WP179_r93002) (Fig.  7A). 
This included suppression of complexes involved in phase 
transitions and checkpoint signaling such as BUB1/BUB3, 
p34cdc2/cyclin B, Chk1/Chk2 and cell cyclin-dependent 
kinases (CDKs) such as CDK1, CDK2 and associated 
cyclins A1, A2, B1, B2 and E1, E2. THP-1 cells treated 
with 1,25(OH)2D also showed decreased expression 
of genes associated with DNA replication (Koren et  al. 
2017 https://www.wikipathways.org/instance/WP466_
r94886) (Fig. 7B). This included suppression of subunits 
of the maintenance protein complex (MCM), needed 
to initiate and elongate the replication fork in the DNA 
replication. 1,25(OH)2D also suppressed expression of 
genes that participate in progression of the cell cycle 
such as components of the assembly of the pre-replicative 
complex. This includes subunits of the component of 
the origin recognition complex (ORC): ORCL 1, 3 and 6. 
Genes that participate in the assembly of pre-replicative 
DNA complexes were also downregulated by 1,25(OH)2D. 
These include CDC6 and CDT1/GMNN complex. Finally, 
components of the DNA polymerase (POLa2, POLa, 
POLe2), primase (PRIM1, PRIM2) and subunits of the 
replication factor C (RFC1–5) were also downregulated by 
1,25(OH)2D in THP-1 cells (Supplementary Fig. 5A and B). 
In contrast to effects in leukemic THP-1 cells, pathways 
associated with cell proliferation and cell cycling were 
unaffected by 1,25(OH)2D in primary cultures of 
monocytes and dendritic cells (Supplementary Fig. 2).
Figure 6
Effect of 1,25(OH)2D on genes associated with the TCA cycle. Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs 
and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted P-values 
<0.05 are shown in green.
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1,25(OH)2D and apoptosis
In the GO analysis, a network that relates apoptosis 
GO terms revealed three GO core groups: (1) negative 
regulation of apoptotic signaling; (2) intrinsic apoptotic 
signaling; (3) regulation of intrinsic apoptotic signaling 
pathway (Supplementary Fig.  3B). These groups include 
genes that were upregulated by 1,25(OH)2D in all three 
cells types such as: NDUFS3, TNFSF10, TRAP1, YBX3, NCK2, 
CEBPB, FXN, CYCS and NCK2. Conversely, CD74, DAPK1, 
ITGAV and FNIP2 were downregulated by 1,25(OH)2D. 
Figure 7
Effect of 1,25(OH)2D on the expression of genes associated with cell proliferation in THP-1 cells. WikiPathways representation of (A) cell cycle; (B) DNA 
replication pathways. Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells. Log2 fold changes are shown as a gradient 
from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted P-values <0.05 are shown in green.
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Biological data in Supplementary Fig.  6A and B show 
significant effects of 1,25(OH)2D on pathways associated 
with apoptosis. The receptor TNFTSF10D that participates 
negatively in apoptosis is upregulated by 1,25(OH)2D in 
all three cell types, while the family of apoptotic caspases 
(2, 3, 4, 6 and 7) and the apoptotic peptidase-activating 
factor 1 (APAF1) are suppressed. Finally, it is interesting 
to note that JAK2 and MAP3K5 are downregulated by 
1,25(OH)2D in THP-1 cells but upregulated in DCs and 
monocytes.
Discussion
Bioinformatics, or applying informatics to study biology, 
seeks to provide an unbiased and statistically robust 
insight into the molecular mechanisms that impact 
human health and disease. Large-scale projects such as 
the Human Genome Project (Roberts et  al. 2001) and 
ENCODE (Consortium et al. 2007) have provided access 
to expansive repositories of data that have greatly helped 
to shed light on genomic function. However, utilization 
of these data repositories to answer specific biological 
questions remains limited. This is particularly true for 
studies of vitamin D, despite detailed genome-wide analysis 
of VDR–chromatin interactions (Pike et al. 2017). In most 
cases, analysis of the genomic responses to 1,25(OH)2D-
VDR complexes has been cell-specific, incorporating both 
classical calciotropic (Meyer et al. 2014) and extra-skeletal 
(Neme et al. 2016) effects of vitamin D. Recently, a more 
integrated approach to the bioinformatic interrogation 
of 1,25(OH)2D-VDR datasets has been described, utilizing 
VDR-chromatin immunoprecipitation-sequencing (ChIP-
Seq) datasets with National Human Genome Research 
Institute (NHGRI) Genome-Wide Association Study 
(GWAS) Single-Nucleotide Polymorphism (SNP) datasets 
(Singh 2017). This strategy of combining publicly available 
datasets presents a distinct set of challenges, notably in 
establishing statistical rigor and appropriate analytical 
workflows, but nevertheless, provides a novel perspective 
on the role of vitamin D and the VDR in human 
health. Notably, integration of ChIP-seq-GWAS datasets 
emphasized an important role for VDR in regulating 
of target genes associated with immunomodulation 
(Singh 2017). The current study proposes an alternative 
bioinformatic approach to further interrogate the 
immunomodulatory function of 1,25(OH)2D-VDR. 
Utilizing pathway analysis workflows to assess multiple 
RNA expression datasets for monocyte-derived cell 
models allowed to the identification of common cellular 
pathways that are regulated by 1,25(OH)2D, revealing an 
important new immunometabolic function for vitamin D. 
The analysis pipeline described here offers an alternative 
statistical approach to conventional software packages. 
The most notable advantage of the workflow presented 
here is that it is open source and user-friendly for the 
bioscience community and enables reproducible and 
straightforward methodology that can process data from 
different gene expression analysis platforms.
Transcriptomic analysis of gene regulatory responses 
has played a pivotal role in defining the innate immune 
functions of vitamin D (Chun et  al. 2014). Notable 
studies have utilized specific monocyte (Liu et  al. 2006) 
and dendritic cell (Ferreira et al. 2015) models to identify 
previously unrecognized molecular targets for active 
1,25(OH)2D, which have, in turn, revealed antibacterial 
(Adams et  al. 2009, Bacchetta et  al. 2014, Chun et  al. 
2015) and metabolic regulatory (Vanherwegen et al. 2017) 
functions for vitamin D in these cells. Collation of data from 
these different studies provides an alternative strategy for 
analysis of the immunomodulatory function of vitamin 
D, by incorporating groups of regulated genes into cellular 
pathway analyses. Using this strategy, it was possible to 
identify common cellular processes that are regulated by 
1,25(OH)2D, as well as those that are more cell lineage 
specific. The major advantage of this workflow is that it 
contextualizes the experimental data at the biological 
process level using interactive pathways. Based on criteria, 
the pathway statistics approach of PathVisio defines the 
genes that are significantly altered in the dataset and 
highlights the pathways of the WikiPathways repository 
that are altered after treatment with 1,25(OH)2D. In our 
pathway analysis, we used the manually curated and 
up-to-date human pathway collection of WikiPathways 
containing a broad spectrum of biological processes, 
including well-described metabolic processes as well as 
signaling and gene regulatory processes. Pathway analysis 
not only highlights the altered biological processes 
based on changes in gene expression, but it enables the 
investigation of the relationship between genes and 
different datasets in great detail. This makes pathway 
analysis a suitable approach for an integrative and 
in-depth analysis of large-scale transcriptomic data.
The most striking observation from the current 
analysis is that in all three cell models, 1,25(OH)2D is 
strongly associated with changes in cellular metabolism, 
oxidative phosphorylation and energy generation. 
Oxidative phosphorylation has been shown to play an 
important role in promoting a tolerogenic phenotype 
in immune cells (Vats et al. 2006, Michalek et al. 2011). 
Previous studies have reported effects of 1,25(OH)2D on 
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mitochondrial functionality and physiology, and pathways 
related to glucose metabolism in monocyte-derived DCs 
(Ferreira et al. 2015). In a similar fashion, serum 25(OH)
D status has been linked to markers of bioenergetic 
pathways in human peripheral blood mononuclear cells 
(Calton et  al. 2016), and active 1,25(OH)2D has been 
shown to increase production of ATP and ROS, as well 
as altering mitochondrial functionality and morphology 
by increasing its membrane potential and total mass of 
mitochondria in differentiating monocytes (Ferreira et al. 
2015). It was therefore notable in the current study that 
the most significantly altered pathways common to all 
three innate immune cell types were those associated with 
mitochondrial function: TCA cycle, electron transport 
chain and oxidative phosphorylation. Collectively, these 
observations underline an important role for 1,25(OH)2D 
as a positive regulator of mitochondrial metabolism and 
bioenergetic pathways in immune cells. Interestingly, this 
effect of 1,25(OH)2D appears to be consistent not only 
across the three myeloid cell models studied in detail in 
Fig. 1, but is also observed within different DC subtypes. 
In the current study, we chose an immature DC (iDC) 
model which focused purely on the effect of 1,25(OH)2D, 
although this was for a longer time period (5  days) 
than the other models. Nevertheless, further analysis 
showed that the pathway effects of 1,25(OH)2D on iDC 
over 5 days were similar to those observed in immune-
activated mature DC (mDC) treated with 1,25(OH)2D for 
12 h (Supplementary Fig. 2).
Pathways associated with glycolysis and 
gluconeogenesis, such as the TCA cycle, were also 
significantly regulated by 1,25(OH)2D in all three 
cell types studied. Catabolism of glucose leads to the 
formation of pyruvate, a biomolecule that is then 
metabolized in the TCA cycle. At present, relatively little 
is known about the impact of vitamin D on the TCA 
cycle, other than clinical studies showing association 
between vitamin D deficiency and dysregulation of 
glucose metabolism like diabetes (Seida et al. 2014). The 
present study demonstrates that several genes involved 
in the glucose metabolism are significantly regulated by 
vitamin D (Supplementary Fig.  4). Comparison of the 
THP-1, DC and monocyte datasets showed that genes 
for enzymes such as hexokinase, phosphofructokinase 
and fructose-bisphosphatase are commonly upregulated 
after 1,25(OH)2D treatment. In contrast to oxidative 
phosphorylation and electron transport, the glycolysis/
gluconeogenesis effects of 1,25(OH)2D were less 
consistent with some genes showing opposite patterns of 
regulation in different cell types. It is nevertheless clear 
that the regulation of glucose metabolism is a key facet of 
1,25(OH)2D regulation of myeloid cells.
Besides common targets for vitamin D in innate 
immune cells, analysis of multiple repositories also 
highlighted pathways that were cell model specific. In 
THP-1 cells only, 1,25(OH)2D potently regulated genes 
involved in progression of cell cycle and DNA replication, 
consistent with the neoplastic origin of these cells. The 
pathways with high Z-score include retinoblastoma in 
cancer, G1 to S cell cycle control, DNA replication and cell 
cycle, are similar to those reported previously for prostate 
cancer cells treated with 1,25(OH)2D (Kutmon et al. 2015a). 
This suggests that, in addition to its common metabolic 
innate immune targets, 1,25(OH)2D also has common 
antiproliferative targets in neoplastic cell types, including 
suppression of key proteins that participate in progression 
of the cell cycle and regulation of DNA replication 
(Kriebitzsch et al. 2009). Interestingly, pathway analysis of 
1,25(OH)2D in prostate cancer cells (Kutmon et al. 2015a) 
did not reveal any significant regulation of the metabolic 
pathways as identified for monocytes and DCs in the 
current study. Thus, in the same way that suppression of 
cell cycle/DNA replication genes appears to be a cancer 
cell-specific effect of 1,25(OH)2D, genes associated with 
oxidative phosphorylation and energy metabolism appear 
to be innate immune cell specific. Previous studies using 
THP-1 cells have also included analysis of the temporal 
variations in response to treatment with 1,25(OH)2D 
(Seuter et al. 2016). The datasets in this particular study 
did not conform to requirements for the comparative 
pathway analysis used in our current study. However, we 
were able to carry out a preliminary pathway analysis of 
these data (Supplementary Fig. 7). Here, it was notable that 
metabolic and cell cycle effects of 1,25(OH)2D were only 
observed after 24 h of treatment, suggesting that pathway 
regulation by vitamin D is highly time dependent.
The third major group of pathways shown to be 
regulated by 1,25(OH)2D in THP-1, monocytes and 
DCs were those associated with programmed cell death 
(apoptosis). Previous studies have reported pro-apoptotic 
effects of 1,25(OH)2D in primary cultures of monocytes, 
with this effect being mediated via interference with 
CD40 responses (Almerighi et  al. 2009). Conversely, in 
the HL-60 leukemic cell line, 1,25(OH)2D was reported to 
promote resistance to apoptosis (Mosieniak et  al. 2006). 
Furthermore, studies from our group have shown that 
antisense knockdown of VDR in another leukemic cell 
line, U937, promoted cell apoptosis (Hewison et al. 1996). 
Data from the current study further support a role for 
1,25(OH)2D in regulating apoptosis of innate immune 
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cells: common genes in the three datasets compared are 
commonly upregulated (TNFTSF10D) and downregulated 
(caspases family proteins and APAF1).
Conclusions
Understanding the entire set of results of high-throughput 
gene expression studies has often been challenging, 
caused by the complicated process of data analysis, 
and the limited biological interpretation that could be 
extracted from the large datasets generated through bench 
experiments. As a consequence, genome-wide analyses 
have tended to focus on changes in expression for specific 
genes (Liu et al. 2006, Chun et al. 2014) or small groups 
of genes associated with a specific pathway (Ferreira et al. 
2015). The aim of the current study was to provide, for 
the first time, an unbiased analysis of the function of 
vitamin D in immune cells at a broader pathway level. 
Our resulting data demonstrate the added value of 
implementing a workflow with different bioinformatic 
tools that allows us to analyze gene expression data in a 
rapid, automated and reproducible fashion, to highlight 
pathways that are significantly altered by 1,25(OH)2D. 
It is possible to visualize and further interrogate these 
biological diagrams to provide a detailed description of 
the molecular effects of 1,25(OH)2D in different types of 
immune cells. Finally, comparison of different datasets has 
allowed us to identify pathways, notably those associated 
with cell metabolism, that are common to multiple 
different types of innate immune cells. This approach 
provides new insights into the immunomodulatory 
actions of vitamin D, but also has important implications 
for the many other physiological responses linked to 
vitamin D in recent studies.
Supplementary data
This is linked to the online version of the paper at https://doi.org/10.1530/
JME-17-0186.
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